Abstract
Extensive epidemiological and experimental evidence suggests the nutritional environment in which a developing conceptus is exposed is a major factor determining later cardiovascular disease. In this review a consideration of the extent to which altered maternal/fetal nutritional environments may predispose toward later anomalies in blood pressure control and hypertension will be undertaken. In particular, a focus will be on potentially novel mechanistic pathways through which early-mid gestational undernutrition may impact upon fetal/adult adipocyte, renal and brain function, that act to increase the risk of later hypertension developing. Within the review we shall also present an opinion on the differing animal models that are currently employed to address developmental programming and introduce a conceptual framework that synthesises current available evidence.
Keywords: Maternal Nutrition, Angiotensin II, Blood Pressure, Hypertension
Current Drug Targets
Title: Fetal Mechanisms That Lead to Later Hypertension
Volume: 8 Issue: 8
Author(s): D.S. Gardner, R.C. Bell and M.E. Symonds
Affiliation:
Keywords: Maternal Nutrition, Angiotensin II, Blood Pressure, Hypertension
Abstract: Extensive epidemiological and experimental evidence suggests the nutritional environment in which a developing conceptus is exposed is a major factor determining later cardiovascular disease. In this review a consideration of the extent to which altered maternal/fetal nutritional environments may predispose toward later anomalies in blood pressure control and hypertension will be undertaken. In particular, a focus will be on potentially novel mechanistic pathways through which early-mid gestational undernutrition may impact upon fetal/adult adipocyte, renal and brain function, that act to increase the risk of later hypertension developing. Within the review we shall also present an opinion on the differing animal models that are currently employed to address developmental programming and introduce a conceptual framework that synthesises current available evidence.
Export Options
About this article
Cite this article as:
D.S. Gardner , R.C. Bell and M.E. Symonds , Fetal Mechanisms That Lead to Later Hypertension, Current Drug Targets 2007; 8 (8) . https://dx.doi.org/10.2174/138945007781386901
DOI https://dx.doi.org/10.2174/138945007781386901 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Old and New Gasotransmitters in the Cardiovascular System: Focus on the Role of Nitric Oxide and Hydrogen Sulfide in Endothelial Cells and Cardiomyocytes
Current Pharmaceutical Biotechnology Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk
Current Pharmaceutical Design Drug release from ordered mesoporous silicas
Current Pharmaceutical Design Diabetic Retinopathy and Atherosclerosis: is there a Link?
Current Diabetes Reviews Chemistry and Pharmacology of Bioactive Molecule -Coenzyme Q10: A Brief Note
Current Bioactive Compounds Recent Advances on Stearoyl-Coa Desaturase Regulation in Fatty Liver Diseases
Current Drug Metabolism Rho-Kinase and RGS-Containing RhoGEFs as Molecular Targets for the Treatment of Erectile Dysfunction
Current Pharmaceutical Design The Discovery of Antiangiogenic Molecules: A Historical Review
Current Pharmaceutical Design Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Diabetes
Current Pharmaceutical Design Primary and Secondary Insomnia: Prevalence, Causes and Current Therapeutics
Current Medicinal Chemistry - Central Nervous System Agents From Dual Peroxisome Proliferator Activated Receptor Agonists to Selective Peroxisome Proliferator Activated Receptor Modulators
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Follicular Cysts: A Single Sign and Different Diseases. A View from Comparative Medicine
Current Pharmaceutical Design Erythropoietin and Oxidative Stress
Current Neurovascular Research Optic Nerve and Cerebral Edema in the Course of Diabetic Ketoacidosis
Current Neuropharmacology Editorial [Hot Topic: Benefits, Problems and Alternatives to COX-2 Inhibition (Guest Editor: Angel Lanas)]
Current Topics in Medicinal Chemistry Cardiac Complications in Hypertension and Diabetes: Role of Sympathetic Nervous Activity
Current Hypertension Reviews Evaluation of Antidiabetic Activity of <i>Rosmarinus officinalis var. prostratus</i> Growing in Syria in Alloxan Diabetic Rats
Current Bioactive Compounds Effect of a Dihydropyridine-Type Calcium Channel Blocker on Vascular Remodelling after Experimental Balloon Angioplasty
Cardiovascular & Hematological Agents in Medicinal Chemistry Nerve Growth Factor: A Focus on Neuroscience and Therapy
Current Neuropharmacology Gender-Specific Relationship Between Uric Acid Levels and Prognosis After Cerebral Venous Thrombosis
Current Neurovascular Research